HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Towards a chemotherapy-free approach in indolent lymphoma.

AuthorsChristian Buske
JournalThe Lancet. Oncology (Lancet Oncol) Vol. 15 Issue 12 Pg. 1281-2 (Nov 2014) ISSN: 1474-5488 [Electronic] England
PMID25439681 (Publication Type: Journal Article, Comment)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Thalidomide
  • Lenalidomide
Topics
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage)
  • Female
  • Humans
  • Lenalidomide
  • Lymphoma, Follicular (drug therapy)
  • Lymphoma, Non-Hodgkin (drug therapy)
  • Male
  • Neoplasm Recurrence, Local (drug therapy)
  • Rituximab
  • Thalidomide (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: